Business
Natco Pharma Limited Press Release Jul 18 2026
Natco Pharma Limited has informed the Exchange regarding a press release dated July 18, 2026, titled "NATCO received Tentative Approval for Olaparib Tablets from the United States Food and Drug Administration (U.S. FDA)".
About this update from Natco Pharma Limited
Natco Pharma Limited has informed the Exchange regarding a press release dated July 18, 2026, titled "NATCO received Tentative Approval for Olaparib Tablets from the United States Food and Drug Administration (U.S. FDA)". View Attachment
View stock analysis, news, and events for Natco Pharma Limited